Healthcare provider profile · identity verified

Jonathan A Clifford, DO

Family Practice · BEAVERCREEK, OH · NPI 1760895940

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	576	186
Levothyroxine Sodium	Levothyroxine Sodium	472	130
Omeprazole	Omeprazole	331	99
Gabapentin	Gabapentin	329	85
Amlodipine Besylate	Amlodipine Besylate	264	88
Metformin Hcl	Metformin Hcl	257	79
Lisinopril	Lisinopril	256	86
Losartan Potassium	Losartan Potassium	241	85
Albuterol Sulfate Hfa	Albuterol Sulfate	146	59
Rosuvastatin Calcium	Rosuvastatin Calcium	145	46
Furosemide	Furosemide	144	49
Trazodone Hcl	Trazodone Hcl	144	41
Sertraline Hcl	Sertraline Hcl	141	46
Metoprolol Succinate	Metoprolol Succinate	137	48
Tramadol Hcl	Tramadol Hcl	136	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	42
Simvastatin	Simvastatin	132	42
Pantoprazole Sodium	Pantoprazole Sodium	128	48
Montelukast Sodium	Montelukast Sodium	125	36
Tamsulosin Hcl	Tamsulosin Hcl	125	44
Metformin Hcl Er	Metformin Hcl	123	38
Pravastatin Sodium	Pravastatin Sodium	119	35
Hydrochlorothiazide	Hydrochlorothiazide	116	39
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	113	21
Eliquis	Apixaban	106	20
Jardiance	Empagliflozin	104	27
Potassium Chloride	Potassium Chloride	103	28
Carvedilol	Carvedilol	97	35
Zolpidem Tartrate	Zolpidem Tartrate	95	21
Tizanidine Hcl	Tizanidine Hcl	90	27
Alendronate Sodium	Alendronate Sodium	89	29
Metoprolol Tartrate	Metoprolol Tartrate	88	31
Alprazolam	Alprazolam	82	17
Allopurinol	Allopurinol	81	28
Duloxetine Hcl	Duloxetine Hcl	81	23
Mounjaro	Tirzepatide	81	19
Diclofenac Sodium	Diclofenac Sodium	77	18
Prednisone	Prednisone	75	40
Escitalopram Oxalate	Escitalopram Oxalate	74	23
Meloxicam	Meloxicam	74	24
Clopidogrel	Clopidogrel Bisulfate	71	22
Buspirone Hcl	Buspirone Hcl	70	19
Finasteride	Finasteride	69	21
Glimepiride	Glimepiride	68	22
Lorazepam	Lorazepam	68	15
Citalopram Hbr	Citalopram Hydrobromide	64	20
Fluticasone Propionate	Fluticasone Propionate	63	21
Clonazepam	Clonazepam	62	12
Glipizide	Glipizide	62	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	22
Methocarbamol	Methocarbamol	59	32
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	13
Methylprednisolone	Methylprednisolone	54	48
Amitriptyline Hcl	Amitriptyline Hcl	52	16
Famotidine	Famotidine	52	20
Ozempic	Semaglutide	51	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	42
Celecoxib	Celecoxib	50	15
Ropinirole Hcl	Ropinirole Hcl	50	11
Bupropion Xl	Bupropion Hcl	49	17
Ibuprofen	Ibuprofen	49	18
Doxazosin Mesylate	Doxazosin Mesylate	43	11
Diazepam	Diazepam	42	suppressed
Fluconazole	Fluconazole	42	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	12
Synthroid	Levothyroxine Sodium	41	16
Venlafaxine Hcl Er	Venlafaxine Hcl	40	13
Glipizide Er	Glipizide	39	15
Topiramate	Topiramate	39	suppressed
Ezetimibe	Ezetimibe	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	16
Ondansetron Hcl	Ondansetron Hcl	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Naproxen	Naproxen	37	20
Ondansetron Odt	Ondansetron	36	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	11
Azithromycin	Azithromycin	34	32
Fenofibrate	Fenofibrate Nanocrystallized	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Valsartan	Valsartan	33	suppressed
Januvia	Sitagliptin Phosphate	32	11
Lovastatin	Lovastatin	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Atenolol	Atenolol	31	12
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	12
Cefuroxime	Cefuroxime Axetil	30	21
Farxiga	Dapagliflozin Propanediol	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	11
Estradiol	Estradiol	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	19
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Klor-Con M20	Potassium Chloride	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	11
Doxycycline Hyclate	Doxycycline Hyclate	25	21
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Olanzapine	Olanzapine	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	20
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Amoxicillin	Amoxicillin	21	suppressed
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Levofloxacin	Levofloxacin	20	15
Benazepril Hcl	Benazepril Hcl	19	suppressed
Ketoconazole	Ketoconazole	19	14
Warfarin Sodium	Warfarin Sodium	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Mometasone Furoate	Mometasone Furoate	18	suppressed
Nystatin	Nystatin	18	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Methimazole	Methimazole	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Oxaprozin	Oxaprozin	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Savella	Milnacipran Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error